Insights and Challenges in Advancing HER2+ Breast Cancer Care

Opinion
Video

Experts review groundbreaking advancements in HER2+ breast cancer treatment, covering curative strategies, metastatic challenges, and the need for ongoing innovation to enhance patient outcomes.

This is a video synopsis/summary of a Peer Exchange involving Joyce O’Shaughnessy, MD; Priyanka Sharma, MD; Claudine Isaacs, MD; Heather McArthur, MD; and Hope S. Rugo, MD, FASCO.

The panel concludes the discussion on HER2-positive breast cancer treatment, emphasizing significant advances in adjuvant, neoadjuvant, and metastatic settings. Isaacs highlights exploring chemotherapy-free regimens for hormone receptor-positive, HER2-positive patients. Sharma underscores the need for further optimization in endocrine therapy and CDK4/6 inhibitor studies. McArthur expresses excitement about the unprecedented era of successful drug development, focusing on brain metastasis and leptomeningeal disease. The importance of enrolling patients in clinical trials is emphasized. Rugo discusses individualizing neoadjuvant therapy and potential strategies for trastuzumab deruxtecan (T-DXd) maintenance. O’Shaughnessy addresses the challenge of treating de novo metastatic cases and the necessity for chronic therapies. The panel collectively advocates for ongoing research and patient-centric care. The discussion provides valuable insights into the evolving landscape of HER2-positive breast cancer treatment.

Video synopsis is AI-generated and reviewed by OncLive® editorial staff.

Related Videos
Video 2 - "Navigating Glioblastoma Imaging: The Patient Journey from Diagnosis to Treatment "
Video 1 - "Neuroimaging of Glioblastoma"
Video 11 - "Pioneering Breakthroughs in HCC Treatment"
Video 18 - "Reflecting on Differentiated Thyroid Cancer: Final Insights"
Video 17 - "Phase 2 ATLEP Trial Results"
Video  10 -"Real-World Evidence on Second-Line Therapy Selection and Outcomes"
Video  9 - "Additional Second-Line Treatments for HCC"
Video 16 - "Neoadjuvant Approach in RAI-R-DTC"
Video 15 - "Addressing Unmet Needs and Challenges in RAI-R-DTC Treatment"
Video 8 - "The Evolving Landscape of Second-Line Therapies in HCC Management"
Related Content